JP2001187705A - Plant disease control agent composition and method for controlling plant disease - Google Patents

Plant disease control agent composition and method for controlling plant disease

Info

Publication number
JP2001187705A
JP2001187705A JP2000317544A JP2000317544A JP2001187705A JP 2001187705 A JP2001187705 A JP 2001187705A JP 2000317544 A JP2000317544 A JP 2000317544A JP 2000317544 A JP2000317544 A JP 2000317544A JP 2001187705 A JP2001187705 A JP 2001187705A
Authority
JP
Japan
Prior art keywords
group
dichlorophenyl
compound
plant disease
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000317544A
Other languages
Japanese (ja)
Other versions
JP4586257B2 (en
Inventor
Norio Kimura
教男 木村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP2000317544A priority Critical patent/JP4586257B2/en
Publication of JP2001187705A publication Critical patent/JP2001187705A/en
Application granted granted Critical
Publication of JP4586257B2 publication Critical patent/JP4586257B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a plant disease control agent composition having a high activity. SOLUTION: This plant disease control agent composition is characterized by containing at least one compound selected from N-(3,5-dichlorophenyl)-1,2- dimethylcyclopropane-1,2-dicarboximide, 3-(3,5-dichlorophenyl)-N-(1- methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide, and 3-(3,5-dichlorophenyl)-5- methyl-5-vinyl-1,3-oxazolidine-2,4-dione, and a pyrazolinone derivative specified in the specification as active ingredients.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、植物病害防除剤組
成物及び植物病害の防除方法に関するものである。
TECHNICAL FIELD The present invention relates to a composition for controlling plant diseases and a method for controlling plant diseases.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】従来
より植物病害を防除するため植物病害防除剤が種々開発
されてきたが、より高活性な植物病害防除剤が常に求め
られている。
2. Description of the Related Art Various plant disease control agents have been developed to control plant diseases. However, more active plant disease control agents have always been required.

【0003】本発明の目的は高い活性を有する植物病害
防除剤組成物及び植物病害を効果的に防除し得る方法を
提供することにある。
An object of the present invention is to provide a composition for controlling plant diseases having high activity and a method for effectively controlling plant diseases.

【0004】[0004]

【課題を解決するための手段】かかる状況下、本発明者
は植物病害防除について検討した結果、ある種のピラゾ
リノン誘導体と特定のイミド化合物とを併用することに
より、植物病害防除において高い相乗効果が得られるこ
とを見出し、本発明に至った。
Under such circumstances, the present inventors have studied the control of plant diseases, and as a result, by using certain pyrazolinone derivatives in combination with a specific imide compound, a high synergistic effect in controlling plant diseases can be obtained. The inventors have found that they can be obtained, and have reached the present invention.

【0005】すなわち本発明は、N−(3,5−ジクロ
ロフェニル)−1,2−ジメチルシクロプロパン−1,
2−ジカルボキシイミド(以下、化合物IIと記す)、3−
(3,5−ジクロロフェニル)−N−(1−メチルエチ
ル)−2,4−ジオキソ−1−イミダゾリジンカルボキ
サミド(以下、化合物IIIと記す)及び3−(3,5−ジ
クロロフェニル)−5−メチル−5−ビニル−1,3−
オキサゾリジン−2,4−ジオン(以下、化合物IVと記
す)から選ばれる少なくとも一種のイミド化合物と、一
般式化2
That is, the present invention relates to N- (3,5-dichlorophenyl) -1,2-dimethylcyclopropane-1,
2-dicarboximide (hereinafter referred to as compound II), 3-
(3,5-dichlorophenyl) -N- (1-methylethyl) -2,4-dioxo-1-imidazolidincarboxamide (hereinafter referred to as compound III) and 3- (3,5-dichlorophenyl) -5-methyl -5-vinyl-1,3-
At least one imide compound selected from oxazolidine-2,4-dione (hereinafter, referred to as compound IV);

【化2】 [式中R1はハロゲン原子またはハロゲン原子で置換さ
れていてもよいメチル基を表し、R2は水素原子、ハロ
ゲン原子またはハロゲン原子で置換されていてもよいメ
チル基を表し、R3はイソプロピル基、セカンダリーブ
チル基、1―エチルプロピル基、1―メチルブチル基、タ
ーシャリブチル基または1,1―ジメチルプロピル基を
表し、R4は酸素原子または硫黄原子を表し、R5はC1
〜C5アルキル基、C2〜C5アルキニル基、C3〜C
5アルケニル基を表す。]で示されるピラゾリノン誘導
体(以下化合物Iと記す)とを有効成分として含有する植
物病害防除剤組成物(以下、本発明組成物として記す)及
び、植物体、植物の栽培地または植物の種子に、化合物
II、III,およびIVから選ばれる少なくとも一種のイミド
化合物及び化合物Iを施用することを特徴とする植物病
害の防除方法(以下、本発明方法と記す)を提供するも
のである。
Embedded image [Wherein R 1 represents a halogen atom or a methyl group optionally substituted with a halogen atom, R 2 represents a hydrogen atom, a halogen atom or a methyl group optionally substituted with a halogen atom, and R 3 represents isopropyl A secondary butyl group, a 1-ethylpropyl group, a 1-methylbutyl group, a tert-butyl group or a 1,1-dimethylpropyl group, R 4 represents an oxygen atom or a sulfur atom, and R 5 represents C1
-C5 alkyl group, C2-C5 alkynyl group, C3-C
5 represents an alkenyl group. A plant disease controlling agent composition (hereinafter, referred to as the present invention composition) containing a pyrazolinone derivative (hereinafter, referred to as compound I) represented by the formula (I) below, and a plant, a plant cultivation area or a plant seed. ,Compound
It is intended to provide a method for controlling plant diseases (hereinafter, referred to as the method of the present invention), which comprises applying at least one imide compound selected from II, III, and IV and compound I.

【0006】[0006]

【発明の実施の形態】まず、化合物Iについて説明す
る。化合物IのR1及びR2において、ハロゲン原子とし
てはフッ素原子、塩素原子等があげられる。ハロゲン原
子で置換されていてもよいメチル基としては、メチル
基、トリフルオロメチル基、トリクロロメチル基等があ
げられる。R5において、C1〜C5アルキル基として
は、メチル基、エチル基、プロピル基、ブチル基等があ
げられ、C2〜C5アルキニル基としては、2−プロピ
ニル基、2−ブチニル基、3−ブチニル基等があげら
れ、C3〜C5アルケニル基としては、2−プロペニル
基、2−ブテニル基、3−ブテニル基等があげられる。
BEST MODE FOR CARRYING OUT THE INVENTION First, compound I will be described. In R 1 and R 2 of compound I, examples of the halogen atom include a fluorine atom and a chlorine atom. Examples of the methyl group which may be substituted with a halogen atom include a methyl group, a trifluoromethyl group and a trichloromethyl group. In R 5, as the C1~C5 alkyl group, a methyl group, an ethyl group, a propyl group, a butyl group, and examples of the C2~C5 alkynyl group, 2-propynyl, 2-butynyl, 3-butynyl group And the C3-C5 alkenyl group includes a 2-propenyl group, a 2-butenyl group and a 3-butenyl group.

【0007】化合物Iは、例えば下記式化3で示される
互変異性体として存在し得るが、本明細書においてはこ
れらおよび他の互変異性体を含めて化合物Iとして表
す。
[0007] Compound I can exist as a tautomer represented by the following formula 3, for example, but in the present specification, these and other tautomers are represented as compound I.

【化3】 また、化合物Iには、二重結合および/または不斉炭素
に基づく立体異性体が存在する場合があるが、化合物I
には、これらの立体異性体およびその2種以上の混合物
が含まれる。化合物Iの具体例を化合物番号と共に表1
に示す(前記一般式化2で示される化合物の各置換基の
定義で示す。)。
Embedded image Compound I may have a stereoisomer based on a double bond and / or an asymmetric carbon.
Include these stereoisomers and mixtures of two or more thereof. Table 1 shows specific examples of Compound I together with the compound numbers.
(Shown in the definition of each substituent of the compound represented by the general formula 2).

【表1】 [Table 1]

【表2】 :表1、表2において、Meはメチル基を、Etはエチ
ル基を、 secBuはsec−ブチル基を、isoPr
はイソプロピル基を表す。また、化合物番号中に(+)
の表記のある化合物は、その化合物がプラスの旋光度
(溶媒:メタノール)を有する光学活性体であることを示
す。(−)の表記がある場合は、その化合物がマイナス
の旋光度(溶媒:メタノール)を有する光学活性体である
ことを示す。
[Table 2]: In Tables 1 and 2, Me represents a methyl group and Et represents ethyl.
Group secBu is a sec-butyl group, isoPr
Represents an isopropyl group. (+) In the compound number
The compound with the notation has a positive optical rotation.
(Optical solvent: methanol)
You. If there is a notation (-), the compound is minus
Optically active substance having optical rotation of (solvent: methanol)
Indicates that

【0008】製造例1 (1)ビス(トリクロロメチル)カ−ボネ−ト0.98
g(3.29mmol)を1,4−ジオキサン10ml
に溶解させ、水冷下、ピリジン0.79g(10.0m
mol)を滴下した。室温で30分攪拌した後、2−プ
ロペン−1−チオ−ル(純度55%)1.35g(10.
0mmol)を滴下し、さらに30分間室温で攪拌した
後、反応液を濾過し、濾液を得た(以下、この濾液を
「濾液A」と記す。)。 (2)3−アミノ−2−tert−ブチル−1−イソプ
ロピル−4−(2,6−ジクロロフェニル)−3−ピラ
ゾリン−5−オン107g(313mmol)に3規定
塩酸300mlとエタノ−ル100mlを加え、還流条
件下で4時間攪拌した。その後、エタノ−ルを減圧留去
し、水層を希水酸化ナトリウム水溶液で中和し、析出した
固体を濾取した。固体を水、および酢酸エチルで洗浄
し、減圧乾燥して化4式の化合物88.4g(309m
mol)を得た。
Production Example 1 (1) Bis (trichloromethyl) carbonate 0.98
g (3.29 mmol) in 1,4-dioxane 10 ml
And pyridine 0.79 g (10.0 m
mol) was added dropwise. After stirring at room temperature for 30 minutes, 1.35 g of 2-propene-1-thiol (55% purity) (10.
0 mmol) was added dropwise, and the mixture was further stirred at room temperature for 30 minutes, and then the reaction solution was filtered to obtain a filtrate (hereinafter, this filtrate is referred to as "filtrate A"). (2) To 107 g (313 mmol) of 3-amino-2-tert-butyl-1-isopropyl-4- (2,6-dichlorophenyl) -3-pyrazolin-5-one was added 300 ml of 3N hydrochloric acid and 100 ml of ethanol. The mixture was stirred under reflux conditions for 4 hours. Thereafter, ethanol was distilled off under reduced pressure, the aqueous layer was neutralized with a dilute aqueous sodium hydroxide solution, and the precipitated solid was collected by filtration. The solid was washed with water and ethyl acetate and dried under reduced pressure to give 88.4 g of the compound of formula (309
mol).

【化4】 なお、3−アミノ−2−tert−ブチル−1−イソプ
ロピル−4−(2,6−ジクロロフェニル)−3−ピラ
ゾリン−5−オンは、特開平8−208621号公報に
記載の方法に準じて製造することが出来る。 (3)(2)で得られた化4の化合物1.41g(4.
93mmol)と水酸化リチウム一水和物0.42g
(10.0mmol)との混合物にトルエン20mlを
加えて共沸脱水操作により水分を除去しつつ、30分間
還流させた。トルエンを減圧留去し、1,4−ジオキサ
ン10mlを加えた。還流下、(1)で得られた「濾液
A」の全量を滴下し、還流条件下でさらに10分間攪拌
した後、1,4−ジオキサンを減圧留去した。残渣に水
を加え、酢酸エチルにて抽出し、有機層を水で2回洗浄
した後、溶媒を減圧留去し、残渣をシリカゲルカラムク
ロマトグラフィ−に付し、化合物I−o0.14g
(0.36mmol)を得た。融点170.8℃なお、
I−o以外の表1および表2に記載の化合物も上述の製
造法に準じた方法で得ることができる。
Embedded image In addition, 3-amino-2-tert-butyl-1-isopropyl-4- (2,6-dichlorophenyl) -3-pyrazolin-5-one was produced according to the method described in JP-A-8-208621. You can do it. (3) 1.41 g of the compound of formula 4 obtained in (2) (4.
93 mmol) and 0.42 g of lithium hydroxide monohydrate
(10.0 mmol) and refluxed for 30 minutes while adding 20 ml of toluene and removing water by an azeotropic dehydration operation. The toluene was distilled off under reduced pressure, and 10 ml of 1,4-dioxane was added. Under reflux, the entire amount of "filtrate A" obtained in (1) was added dropwise, and the mixture was further stirred for 10 minutes under reflux conditions, and 1,4-dioxane was distilled off under reduced pressure. Water was added to the residue, and the mixture was extracted with ethyl acetate. The organic layer was washed twice with water, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography to obtain 0.14 g of compound I-o.
(0.36 mmol) was obtained. Melting point 170.8 ° C
The compounds described in Tables 1 and 2 other than Io can also be obtained by a method according to the above-mentioned production method.

【0009】N−(3,5−ジクロロフェニル)−1,
2−ジメチルシクロプロパン−1,2−ジカルボキシイ
ミドは一般名プロシミドン、3−(3,5−ジクロロフ
ェニル)−N−(1−メチルエチル)−2,4−ジオキ
ソ−1−イミダゾリジンカルボキサミドは一般名イプロ
ジオン、そして3−(3,5−ジクロロフェニル)−5
−メチル−5−ビニル−1,3−オキサゾリジン−2,
4−ジオンは一般名ビンクロゾリンとして知られた化合
物であり、これらは、Farm Chemicals Handbook99
年度版のC−318ページ(プロシミドン)、C−22
4ページ(イプロジオン)、C−407ページ(ビンク
ロゾリン)にそれぞれ記載され、また市販の化合物であ
る。
N- (3,5-dichlorophenyl) -1,
2-dimethylcyclopropane-1,2-dicarboximide is a general name procymidone, and 3- (3,5-dichlorophenyl) -N- (1-methylethyl) -2,4-dioxo-1-imidazolidincarboxamide is a general name The name iprodione and 3- (3,5-dichlorophenyl) -5
-Methyl-5-vinyl-1,3-oxazolidine-2,
4-diones are compounds known under the generic name vinclozolin, and are described in the Farm Chemicals Handbook 99
Fiscal version page C-318 (procimidon), C-22
It is described on page 4 (iplodione) and page C-407 (vinclozolin), respectively, and is a commercially available compound.

【0010】本発明により防除することができる植物病
害としては例えば以下の病害をあげることができる。通
常、本発明方法においては、本発明組成物が用いられ
る。イネのいもち病(Pyricularia oryzae)、ごま葉枯
病(Cochliobolus miyabeanus)、紋枯病(Rhizoctonia
solani)、ムギ類のうどんこ病(Erysiphe graminis)、
赤かび病(Gibberella zeae)、さび病(Puccinia strii
formis, P. graminis, P. recondita, P. hordei)、雪
腐病(Typhula sp.,Micronectriella nivalis)、裸黒穂
病 (Ustilago tritici, U. nuda)、なまぐさ黒穂病 (Ti
lletia caries)、眼紋病(Pseudocercosporella herpot
richoides)、雲形病(Rhynchosporiumsecalis) 、葉枯
病(Septoria tritici)、ふ枯病(Leptosphaeria nodo
rum)、カンキツ類の黒点病(Diaporthe citri)、そうか
病(Elsinoe fawcetti) 、果実腐敗病 (Penicillium di
gitatum, P. italicum) 、リンゴのモニリア病 (Sclero
tinia mali) 、腐らん病 (Valsa mali) 、うどんこ病
(Podosphaera leucotricha)、斑点落葉病(Alternaria
mali)、黒星病(Venturia inaequalis)、ナシの黒星病
(Venturia nashicola, V. pirina)、黒斑病(Alternar
ia kikuchiana)、赤星病(Gymnosporangium haraeanu
m)、モモの灰星病(Sclerotinia cinerea)、黒星病(Cl
adosporium carpophilum) 、フォモプシス腐敗病(Phom
opsis sp.)、ブドウの黒とう病(Elsinoe ampelina) 、
晩腐病(Glomerella cingulata) 、うどんこ病(Uncinu
la necator) 、さび病 (Phakopsora ampelopsidis)、ブ
ラックロット病(Guignardia bidwellii) 、べと病(Pl
asmopara viticola)、カキの炭そ病(Gloeosporium kak
i)、落葉病 (Cercospora kaki, Mycosphaerella nawa
e)、ウリ類の炭そ病(Colletotrichum lagenarium)、う
どんこ病(Sphaerotheca fuliginea) 、つる枯病 (Myco
sphaerella melonis) 、つる割病 (Fusarium oxysporu
m) 、べと病 (Pseudoperonospora cubensis) 、疫病(P
hytophthora sp.) 、苗立枯病 (Pythium sp.)、トマト
の輪紋病(Alternaria solani)、葉かび病 (Cladospori
um fulvum)、疫病(Phytophthora infestans) 、ナスの
褐紋病(Phomopsis vexans) 、うどんこ病(Erysiphe c
ichoracearum) 、アブラナ科野菜の黒斑病(Alternaria
japonica)、白斑病(Cercosporella brassicae)、ネギ
のさび病(Puccinia allii) 、ダイズの紫斑病(Cercos
pora kikuchii)、黒とう病(Elsinoe glycines) 、黒点
病 (Diaporthe phaseolorum var. sojae) 、インゲンの
炭そ病(Colletotrichum lindemthianum) 、ラッカセイ
の黒渋病(Cercospora personata)、褐斑病(Cercospor
a arachidicola)、エンドウのうどんこ病(Erysiphepis
i)、ジャガイモの夏疫病(Alternaria solani)、疫病
(Phytophthora infestans) 、イチゴのうどんこ病(Sp
haerotheca humuli)、チャの網もち病(Exobasidium re
ticulatum)、白星病(Elsinoe leucospila) 、タバコの
赤星病(Alternaria longipes)、うどんこ病(Erysiphe
cichoracearum) 、炭そ病(Colletotrichum tabacum)
、べと病(Peronospora tabacina) 、疫病(Phytophth
ora nicotianae)、テンサイの褐斑病(Cercospora beti
cola)、バラの黒星病(Diplocarponrosae)、うどんこ病
(Sphaerotheca pannosa) 、キクの褐班病 (Septoria c
hrysanthemi−indici) 、白さび病(Puccinia horiana)
、種々の作物の灰色かび病(Botrytis cinerea) 、菌
核病(Sclerotinia sclerotiorum) 等なお、本発明組成
物はイプロジオン、プロシミドン、ビンクロゾリン等の
イミド化合物に耐性を有する菌(病害)に対しても、優れ
た防除効果を示す。
[0010] Plant diseases that can be controlled by the present invention include, for example, the following diseases. Usually, in the method of the present invention, the composition of the present invention is used. Rice blast (Pyricularia oryzae), sesame leaf blight (Cochliobolus miyabeanus), sheath blight (Rhizoctonia)
solani), powdery mildew of wheat (Erysiphe graminis),
Fusarium head blight (Gibberella zeae), rust (Puccinia strii)
formis, P. graminis, P. recondita, P. hordei), snow rot (Typhula sp., Micronectriella nivalis), naked smut (Ustilago tritici, U. nuda), black smut (Ti.
lletia caries), eye spot disease (Pseudocercosporella herpot)
richoides), scald (Rhynchosporiumsecalis), leaf blight (Septoria tritici), blight (Leptosphaeria nodo)
rum), citrus black spot (Diaporthe citri), scab (Elsinoe fawcetti), fruit rot (Penicillium di
gitatum, P. italicum) and Monilia disease of apples (Sclero
tinia mali), rot (Valsa mali), powdery mildew (Podosphaera leucotricha), spot leaf spot (Alternaria
mali), scab (Venturia inaequalis), pear scab (Venturia nashicola, V. pirina), black spot (Alternar
ia kikuchiana), scab (Gymnosporangium haraeanu)
m), peach scab (Sclerotinia cinerea), scab (Cl
adosporium carpophilum), Phomopsis rot (Phom
opsis sp.), black currant on grape (Elsinoe ampelina),
Late rot (Glomerella cingulata), powdery mildew (Uncinu)
la necator), rust (Phakopsora ampelopsidis), black lot disease (Guignardia bidwellii), downy mildew (Pl
asmopara viticola), oyster anthracnose (Gloeosporium kak)
i), deciduous disease (Cercospora kaki, Mycosphaerella nawa
e), cucumber anthracnose (Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), vine blight (Myco
sphaerella melonis), vine disease (Fusarium oxysporu)
m), downy mildew (Pseudoperonospora cubensis), plague (P
hytophthora sp.), seedling blight (Pythium sp.), tomato ring spot (Alternaria solani), leaf mold (Cladospori)
um fulvum), plague (Phytophthora infestans), eggplant brown spot (Phomopsis vexans), powdery mildew (Erysiphe c)
ichoracearum), black spot of cruciferous vegetables (Alternaria
japonica), white spot (Cercosporella brassicae), green onion rust (Puccinia allii), soybean purpura (Cercos
pora kikuchii), black rot (Elsinoe glycines), black spot (Diaporthe phaseolorum var. sojae), kidney anthracnose (Colletotrichum lindemthianum), peanut black rot (Cercospora personata), brown spot (Cercospor)
a arachidicola), pea powdery mildew (Erysiphepis)
i), potato summer blight (Alternaria solani), blight (Phytophthora infestans), strawberry powdery mildew (Sp
haerotheca humuli), tea net blast (Exobasidium re
ticulatum), scab (Elsinoe leucospila), tobacco scab (Alternaria longipes), powdery mildew (Erysiphe)
cichoracearum), Anthracnose (Colletotrichum tabacum)
, Downy mildew (Peronospora tabacina), plague (Phytophth
ora nicotianae), brown spot of sugar beet (Cercospora beti)
cola), rose scab (Diplocarponrosae), powdery mildew (Sphaerotheca pannosa), chrysanthemum spot on chrysanthemum (Septoria c
hrysanthemi-indici), white rust (Puccinia horiana)
The composition of the present invention can also be used against bacteria (disease) resistant to imide compounds such as iprodione, procymidone, vinclozolin, etc. Shows excellent control effect.

【0011】本発明組成物において、化合物II、III及
びIVから選ばれる少なくとも1種のイミド化合物と化合
物Iとの割合は、重量比で通常0.5〜8:1、好まし
くは1〜2:1である。
In the composition of the present invention, the ratio of the compound I to at least one imide compound selected from the compounds II, III and IV is usually 0.5 to 8: 1 by weight, preferably 1-2: It is one.

【0012】本発明組成物を本発明方法に用いる場合
は、他の何らの成分も加えず化合物II、III及びIVから
選ばれる少なくとも1種のイミド化合物及び化合物I
(以下、本有効成分と記す)をそのまま用いてもよい
が、通常は本有効成分を、固体担体、液体担体、ガス担
体、界面活性剤等と混合し、必要により固着剤、分散
剤、安定剤等の製剤用補助剤を添加して、水和剤、フロ
アブル剤、粒剤、ドライフロアブル剤、乳剤、水性液
剤、油剤、くん煙剤、エアゾール剤、マイクロカプセル
剤等に製剤化して用いる。これらの製剤には本有効成分
が重量比で通常0.1〜99%、好ましくは0.2〜9
0%含有される。
When the composition of the present invention is used in the method of the present invention, at least one imide compound selected from compounds II, III and IV and compound I without any other component are added.
(Hereinafter, referred to as the present active ingredient) may be used as it is, but usually, the present active ingredient is mixed with a solid carrier, a liquid carrier, a gas carrier, a surfactant and the like, and if necessary, a fixing agent, a dispersant, and a stabilizing agent. Formulation auxiliaries such as preparations are added to make wettable powders, flowables, granules, dry flowables, emulsions, aqueous solutions, oils, smokes, aerosols, microcapsules and the like. In these preparations, the active ingredient is usually 0.1 to 99% by weight, preferably 0.2 to 9% by weight.
0% is contained.

【0013】製剤化の際に用いられる固体担体として
は、例えばカオリンクレ−、アッタパルジャイトクレ
−、ベントナイト、モンモリロナイト、酸性白土、パイ
ロフィライト、タルク、珪藻土、方解石等の鉱物質、ト
ウモロコシ穂軸粉、クルミ殻粉等の天然有機物、尿素等
の合成有機物、炭酸カルシウム、硫酸アンモニウム等の
塩類、合成含水酸化珪素等の合成無機物の微粉末あるい
は粒状物等があげられ、液体担体としては、例えばキシ
レン、アルキルベンゼン、メチルナフタレン等の芳香族
炭化水素類、イソプロパノ−ル、エチレングリコ−ル、
プロピレングリコール、セロソルブ等のアルコ−ル類、
アセトン、シクロヘキサノン、イソホロン等のケトン
類、ダイズ油、綿実油等の植物油、石油系脂肪族炭化水
素、エステル類、ジメチルスルホキシド、アセトニトリ
ル、水等があげられる。界面活性剤としては、例えばア
ルキル硫酸エステル塩、アルキル(アリ−ル)スルホン
酸塩、ジアルキルスルホコハク酸塩、ポリオキシエチレ
ンアルキルアリ−ルエ−テルリン酸エステル塩、リグニ
ンスルホン酸塩、ナフタレンスルホン酸ホルマリン縮合
物等の陰イオン界面活性剤、ポリオキシエチレンアルキ
ルアリールエーテル、ポリオキシエチレンアルキルポリ
オキシプロピレンブロックコポリマ−、ソルビタン脂肪
酸エステル等の非イオン界面活性剤等があげられる。ガ
ス担体としてはブタンやプロパンなどのLPG、または
窒素や二酸化炭素などが挙げられる。製剤用補助剤とし
ては、例えばポリビニルアルコ−ル、ポリビニルピロリ
ドン等の水溶性高分子、アラビアガム、アルギン酸また
はその塩、CMC(カルボキシメチルセルロ−ス)、ザ
ンサンガム等の多糖類、アルミニウムマグネシウムシリ
ケート、アルミナゾル等の無機物、防腐剤、着色剤、P
AP(酸性リン酸イソプロピル)、BHT等の安定化剤
等があげられる。
Examples of the solid carrier used in the preparation include minerals such as kaolin clay, attapargite clay, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth, calcite, and corn cob powder. , Natural organic substances such as walnut shell powder, synthetic organic substances such as urea, salts such as calcium carbonate and ammonium sulfate, fine powders or granular substances of synthetic inorganic substances such as synthetic silicon oxide hydroxide, and the like. Examples of the liquid carrier include xylene, Aromatic hydrocarbons such as alkylbenzene and methylnaphthalene, isopropanol, ethylene glycol,
Alcohols such as propylene glycol and cellosolve,
Examples include ketones such as acetone, cyclohexanone and isophorone, vegetable oils such as soybean oil and cottonseed oil, petroleum aliphatic hydrocarbons, esters, dimethyl sulfoxide, acetonitrile, and water. Examples of the surfactant include alkyl sulfate, alkyl (aryl) sulfonate, dialkyl sulfosuccinate, polyoxyethylene alkyl aryl ether phosphate, lignin sulfonate, and naphthalene sulfonate formalin condensation. Surfactants, and nonionic surfactants such as polyoxyethylene alkylaryl ether, polyoxyethylene alkyl polyoxypropylene block copolymer, and sorbitan fatty acid ester. Examples of the gas carrier include LPG such as butane and propane, and nitrogen and carbon dioxide. Examples of the formulation auxiliary include water-soluble polymers such as polyvinyl alcohol and polyvinyl pyrrolidone, gum arabic, alginic acid or a salt thereof, polysaccharides such as CMC (carboxymethylcellulose) and xanthan gum, aluminum magnesium silicate, and alumina sol. Inorganic substances, preservatives, coloring agents, P
Stabilizers such as AP (acidic isopropyl phosphate) and BHT are exemplified.

【0014】また、例えば本有効成分のそれぞれを上述
の手法により別々に製剤化し、必要により更に水でそれ
ぞれを希釈した後、該別々に調製された製剤または該別
々に調製された希釈液を混合することにより本発明組成
物を調製することもできる。
Also, for example, each of the present active ingredients is separately formulated by the above-mentioned method, and if necessary, each is further diluted with water, and then the separately prepared preparation or the separately prepared diluent is mixed. By doing so, the composition of the present invention can also be prepared.

【0015】本発明組成物を施用する方法としては、実
質的に本発明組成物が施用され得る形態であればその方
法は特に限定されないが、例えば茎葉散布などの植物体
への処理、土壌処理などの植物の栽培地への処理、種子
消毒などの種子への処理等があげられる。
The method of applying the composition of the present invention is not particularly limited as long as the composition of the present invention can be applied substantially. Examples thereof include treatment of plants such as foliage application and soil treatment. And the like, and treatment of seeds such as seed disinfection.

【0016】本発明方法において、本有効成分の施用量
は、対象植物(作物等)の種類、対象病害の種類、病害
の発生程度、製剤形態、施用方法、施用時期、気象条件
等によって変化し得るが、1ア−ルあたり通常0.1〜
50g、好ましくは1〜10gであり、また本有効成分
中の化合物II、III及びIVから選ばれる少なくとも1種
のイミド化合物と化合物Iとの割合は、重量比で通常
0.5〜8:1、好ましくは1〜2:1である。乳剤、
水和剤、懸濁剤等は通常水で希釈して施用され、本有効
成分濃度は、通常0.0005〜2%、好ましくは0.
005〜1%であり、粉剤、粒剤等は通常希釈すること
なくそのまま施用される。種子への処理においては、種
子1Kgに対して本有効成分は通常0.001〜100
g、好ましくは0.01〜50gの範囲で施用される。
In the method of the present invention, the application rate of the present active ingredient varies depending on the type of the target plant (crop etc.), the type of the target disease, the degree of occurrence of the disease, the formulation, the application method, the application time, the weather conditions, and the like. But usually 0.1-per arc
50 g, preferably 1 to 10 g, and the ratio of compound I to at least one imide compound selected from compounds II, III and IV in the present active ingredient is usually 0.5 to 8: 1 by weight. , Preferably 1-2: 1. emulsion,
The wettable powder, the suspending agent and the like are usually applied after being diluted with water, and the active ingredient concentration is usually 0.0005 to 2%, preferably 0.1 to 0.5%.
005% to 1%, and powders, granules and the like are usually applied without dilution. In the treatment of seed, the present active ingredient is usually 0.001 to 100 per 1 kg of seed.
g, preferably in the range of 0.01 to 50 g.

【0017】[0017]

【実施例】以下、製剤例および試験例にて本発明をさら
に詳しく説明するが、本発明は以下の例のみに限定され
るものではない。なお、以下の例において、部は特にこ
とわりの無い限り重量部を表す。また、化合物Iについ
ては前記表1及び表2に記載の化合物番号で示す。
EXAMPLES The present invention will be described in more detail with reference to Formulation Examples and Test Examples, but the present invention is not limited to the following Examples. In the following examples, parts are by weight unless otherwise specified. Compound I is indicated by the compound number shown in Tables 1 and 2.

【0018】製剤例1 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を2.5部、化合物IIを2.5部、ポリオキシエ
チレンスチリルフェニルエ−テル14部、ドデシルベン
ゼンスルホン酸カルシウム6部及びキシレン75部をよ
く混合することにより各乳剤を得る。
Formulation Example 1 Compounds (Ia), (Ib), (Ic), (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
Each emulsion is obtained by thoroughly mixing 2.5 parts of -p), 2.5 parts of compound II, 14 parts of polyoxyethylenestyrylphenyl ether, 6 parts of calcium dodecylbenzenesulfonate and 75 parts of xylene.

【0019】製剤例2 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を5部、化合物IIを5部、ホワイトカーボンとポ
リオキシエチレンアルキルエーテルサルフェートアンモ
ニウム塩との混合物(重量割合1:1)35部及び水55
部を混合し、湿式粉砕法で微粉砕することにより各フロ
アブル製剤を得る。
Formulation Example 2 Compounds (Ia), (Ib), (Ic) and (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
5 parts of p), 5 parts of compound II, 35 parts of a mixture of white carbon and ammonium polyoxyethylene alkyl ether sulfate (weight ratio 1: 1) and 55 parts of water.
Parts are mixed and finely pulverized by a wet pulverization method to obtain each flowable preparation.

【0020】製剤例3 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を5部、化合物IIを10部、ソルビタントリオレ
エ−ト1.5部及びポリビニルアルコ−ル2部を含む水溶
液28.5部を混合し、湿式粉砕法で微粉砕した後、この中
にキサンタンガム0.05部及びアルミニウムマグネシウム
シリケ−ト0.1部を含む水溶液45部を加え、さらにプ
ロピレングリコ−ル10部を加えて攪拌混合し各フロア
ブル製剤を得る。
Formulation Example 3 Compounds (Ia), (Ib), (Ic) and (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
-P), 5 parts of compound II, 10 parts of compound II, 1.5 parts of sorbitan trioleate and 28.5 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed, finely pulverized by a wet pulverization method, and 0.5 g of xanthan gum was added thereto. And 45 parts of an aqueous solution containing 0.1 part of aluminum magnesium silicate, and 10 parts of propylene glycol are further added and stirred and mixed to obtain each flowable preparation.

【0021】製剤例4 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を1部、化合物IIを2.5部、合成含水酸化珪
素1部、リグニンスルホン酸カルシウム2部、ベントナ
イト30部及びカオリンクレ−63.5部をよく粉砕混
合し、水を加えてよく練り合せた後、造粒乾燥すること
により各粒剤を得る。
Formulation Example 4 Compounds (Ia), (Ib), (Ic) and (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
-P), 1 part of compound II, 2.5 parts of synthetic hydrous silicon oxide, 1 part of synthetic hydrated calcium hydroxide, 2 parts of calcium ligninsulfonate, 30 parts of bentonite and 63.5 parts of kaolin kure, well mixed and added with water. After kneading, each granule is obtained by granulation and drying.

【0022】製剤例5 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を12.5部、化合物IIを37.5部、リグニン
スルホン酸カルシウム3部、ラウリル硫酸ナトリウム2
部及び合成含水酸化珪素45部をよく粉砕混合すること
により各水和剤を得る。
Formulation Example 5 Compounds (Ia), (Ib), (Ic) and (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
-P) 12.5 parts, compound II 37.5 parts, calcium lignin sulfonate 3 parts, sodium lauryl sulfate 2
Parts and 45 parts of synthetic hydrous silicon oxide are thoroughly pulverized and mixed to obtain each wettable powder.

【0023】製剤例6 化合物(I−a)、(I−b)、(I−c)、(I−
d)、(I−e)、(I−f)、(I−g)、(I−
h)、(I−i)、(I−j)、(I−k)、(I−
l)、(I−m)、(I−n)、(I−o)または(I
−p)を1部、化合物IIを2部、カオリンクレ−85部
及びタルク10部をよく粉砕混合することにより各粉剤
を得る。
Formulation Example 6 Compounds (Ia), (Ib), (Ic), (I-
d), (Ie), (If), (Ig), (I-
h), (Ii), (Ij), (Ik), (I-
l), (Im), (In), (Io) or (I
-P), 1 part of Compound II, 2 parts of Compound II, 85 parts of Kaolin Kure and 10 parts of talc are thoroughly pulverized and mixed to obtain each powder.

【0024】試験例1 プラスチックポットに砂壌土を詰め、キュウリ(相模半
白)を播種し、温室内で12日間生育させた。化合物(I
−j)の水和剤とプロシミドンの水和剤をそれぞれ水で
希釈した後タンクミックスし、所定濃度の化合物(I−
j)およびプロシミドンを有効成分とするタンクミック
ス液を調整した。該タンクミックス液を前記キュウリの
葉面に充分付着するように茎葉散布した。散布後植物を
風乾し、プロシミドン耐性のキュウリ灰色かび病菌の胞
子含有PDA培地をキュウリ葉面上に置いた。接種後10
℃、多湿下に6日間置いた後、防除効果を調査した。ま
た、比較のために前記のそれぞれの水和剤を水希釈して
所定濃度とした化合物(I−j)液及びプロシミドン液
を調整しそれぞれ、同様の防除試験を行った。また、防
除価算出のために薬剤無処理における発病度もあわせて
調査した。調査時には以下の評価指数を用いた。式1よ
り発病度を算出し、その発病度をもとに、式2を用い防
除価(%)を算出した。その結果を表3に示す。
Test Example 1 A plastic pot was filled with sandy loam, cucumber (Sagami Hanjiro) was sowed, and grown in a greenhouse for 12 days. Compound (I
-J) wettable powder and procymidone wettable powder were each diluted with water and then mixed with a tank to give a compound (I-
A tank mix solution containing j) and procymidone as active ingredients was prepared. The tank mix solution was sprayed on foliage so as to sufficiently adhere to the leaf surface of the cucumber. After spraying, the plants were air-dried, and a PDA medium containing spores of cucumber gray mold fungus resistant to procymidone was placed on the cucumber leaves. 10 after inoculation
After 6 days under high temperature and high temperature, the control effect was investigated. For comparison, a compound (I-j) solution and a procymidone solution were prepared by diluting each of the above wettable powders with water to a predetermined concentration, and the same control test was performed. In addition, the disease severity in the case of no treatment was also investigated for calculating the control value. The following evaluation indices were used during the survey. The disease severity was calculated from Formula 1, and the control value (%) was calculated using Formula 2 based on the disease severity. The results are shown in Table 3.

【0025】試験例2−4 化合物(I−j)にかえて化合物(I−i)、(I−n)
または(I−o)を用いる以外は同様の実験を行った。
その結果を表3に示す。
Test Example 2-4 Compounds (Ii) and (In) in place of compound (Ij)
Or the same experiment was performed except that (Io) was used.
The results are shown in Table 3.

【0026】評価指数 0:病斑直径0mm、1:1―5mm、2:5−10m
m、3:10―15mm、4:15−20mm、5:>
20mm
Evaluation index 0: Lesion diameter 0 mm, 1: 1-5 mm, 2: 5-10 m
m, 3: 10-15 mm, 4: 15-20 mm, 5:>
20mm

【式1】発病度=Σ(調査葉の評価指数)×100/
(5×調査葉数)
[Formula 1] Disease incidence = Σ (evaluation index of survey leaf) x 100 /
(5 x number of leaves surveyed)

【式2】防除価(%)=100×(A−B)/A A:無処理区の植物の発病度 B:処理区の植物の発病度 一般に、与えられた2種類の有効成分化合物を混合して
処理した際に期待される防除効果、いわゆる防除価期待
値は下記の式3のコルビーの計算式により求められる。
Formula 2: Control value (%) = 100 × (A−B) / A A: Degree of disease on plants in untreated area B: Degree of disease on plants in treated area In general, given two types of active ingredient compounds The control effect expected when mixed and treated, that is, the so-called expected value of the control value, can be obtained by Colby's calculation formula of the following formula 3.

【式3】E=X+Y−(XY)/100 X:有効成分化合物AをMppmで処理した時の防除価
(%) Y:有効成分化合物BをNppmで処理した時の防除価
(%) E:有効成分化合物AをMppmで、有効成分化合物B
をNppmで処理した時に期待される防除価(%)(防
除価期待値)
Formula 3: E = X + Y- (XY) / 100 X: Control value (%) when active compound A is treated with Mppm Y: Control value (%) when active compound B is treated with Nppm : Active ingredient compound A in Mppm, active ingredient compound B
Value (%) (expected control value) expected when N is treated with Nppm

【表3】 [Table 3]

【0027】[0027]

【発明の効果】本発明によれば、植物病害を効果的に防
除することが可能となる。
According to the present invention, it is possible to effectively control plant diseases.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】N−(3,5−ジクロロフェニル)−1,
2−ジメチルシクロプロパン−1,2−ジカルボキシイ
ミド、3−(3,5−ジクロロフェニル)−N−(1−
メチルエチル)−2,4−ジオキソ−1−イミダゾリジ
ンカルボキサミド及び3−(3,5−ジクロロフェニ
ル)−5−メチル−5−ビニル−1,3−オキサゾリジ
ン−2,4−ジオンから選ばれる少なくとも一種のイミ
ド化合物と、一般式化1 【化1】 [式中R1はハロゲン原子またはハロゲン原子で置換さ
れていてもよいメチル基を表し、R2は水素原子、ハロ
ゲン原子またはハロゲン原子で置換されていてもよいメ
チル基を表し、R3はイソプロピル基、セカンダリーブ
チル基、1―エチルプロピル基、1―メチルブチル基、タ
ーシャリブチル基または1,1―ジメチルプロピル基を
表し、R4は酸素原子または硫黄原子を表し、R5はC1
〜C5アルキル基、C2〜C5アルキニル基またはC3
〜C5アルケニル基を表す。]で示されるピラゾリノン
誘導体とを有効成分として含有することを特徴とする植
物病害防除剤組成物。
(1) N- (3,5-dichlorophenyl) -1,
2-dimethylcyclopropane-1,2-dicarboximide, 3- (3,5-dichlorophenyl) -N- (1-
At least one selected from methylethyl) -2,4-dioxo-1-imidazolidinecarboxamide and 3- (3,5-dichlorophenyl) -5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione And an imide compound of the general formula 1 [Wherein R 1 represents a halogen atom or a methyl group optionally substituted with a halogen atom, R 2 represents a hydrogen atom, a halogen atom or a methyl group optionally substituted with a halogen atom, and R 3 represents isopropyl A secondary butyl group, a 1-ethylpropyl group, a 1-methylbutyl group, a tert-butyl group or a 1,1-dimethylpropyl group, R 4 represents an oxygen atom or a sulfur atom, and R 5 represents C1
-C5 alkyl group, C2-C5 alkynyl group or C3
Represents a CC5 alkenyl group. And a pyrazolinone derivative represented by the formula (1) as an active ingredient.
【請求項2】植物体、植物の栽培地または植物の種子
に、N−(3,5−ジクロロフェニル)−1,2−ジメ
チルシクロプロパン−1,2−ジカルボキシイミド、3
−(3,5−ジクロロフェニル)−N−(1−メチルエ
チル)−2,4−ジオキソ−1−イミダゾリジンカルボ
キサミド及び3−(3,5−ジクロロフェニル)−5−
メチル−5−ビニル−1,3−オキサゾリジン−2,4
−ジオンから選ばれる少なくとも一種のイミド化合物及
び請求項1に記載のピラゾリノン誘導体を施用すること
を特徴とする植物病害の防除方法。
2. The method according to claim 1, wherein the plant, the cultivation area of the plant, or the seed of the plant is N- (3,5-dichlorophenyl) -1,2-dimethylcyclopropane-1,2-dicarboximide,
-(3,5-dichlorophenyl) -N- (1-methylethyl) -2,4-dioxo-1-imidazolidinecarboxamide and 3- (3,5-dichlorophenyl) -5
Methyl-5-vinyl-1,3-oxazolidine-2,4
A method for controlling plant diseases, which comprises applying at least one imide compound selected from -dione and the pyrazolinone derivative according to claim 1.
JP2000317544A 1999-10-21 2000-10-18 Plant disease control composition and plant disease control method Expired - Fee Related JP4586257B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000317544A JP4586257B2 (en) 1999-10-21 2000-10-18 Plant disease control composition and plant disease control method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11-299474 1999-10-21
JP29947499 1999-10-21
JP2000317544A JP4586257B2 (en) 1999-10-21 2000-10-18 Plant disease control composition and plant disease control method

Publications (2)

Publication Number Publication Date
JP2001187705A true JP2001187705A (en) 2001-07-10
JP4586257B2 JP4586257B2 (en) 2010-11-24

Family

ID=26561948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000317544A Expired - Fee Related JP4586257B2 (en) 1999-10-21 2000-10-18 Plant disease control composition and plant disease control method

Country Status (1)

Country Link
JP (1) JP4586257B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249067A (en) * 2004-10-27 2006-09-21 Sumitomo Chemical Co Ltd Granular agrochemical composition
JP2011522005A (en) * 2008-06-05 2011-07-28 ビーエーエスエフ ソシエタス・ヨーロピア Synergistic fungicide mixture

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5789918B2 (en) 2010-04-28 2015-10-07 住友化学株式会社 Plant disease control composition and use thereof
JP5360244B2 (en) * 2012-02-08 2013-12-04 住友化学株式会社 Plant disease control composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226374A (en) * 1998-04-23 2000-08-15 Sumitomo Chem Co Ltd Pyrazolinone derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000226374A (en) * 1998-04-23 2000-08-15 Sumitomo Chem Co Ltd Pyrazolinone derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249067A (en) * 2004-10-27 2006-09-21 Sumitomo Chemical Co Ltd Granular agrochemical composition
JP2011522005A (en) * 2008-06-05 2011-07-28 ビーエーエスエフ ソシエタス・ヨーロピア Synergistic fungicide mixture

Also Published As

Publication number Publication date
JP4586257B2 (en) 2010-11-24

Similar Documents

Publication Publication Date Title
JP5034142B2 (en) Plant disease control composition
JP3633578B2 (en) Disinfectant composition
WO2015050040A1 (en) Plant disease control composition and use thereof
JP3726306B2 (en) Pyrazolecarboxylic acid derivatives and plant disease control agents
JP2009078991A (en) Thiophene carboxylic acid derivative and its manufacturing method, and bactericide
US6294567B1 (en) Pyrazolinone derivatives
JP2007145816A (en) Amide compound and its use
JP4090638B2 (en) Plant disease control composition
JPH11302111A (en) Composition of plant disease injury controlling agent
JP4586257B2 (en) Plant disease control composition and plant disease control method
EP1222856B1 (en) Plant disease controlling compositions and plant disease controlling method
WO2017090664A1 (en) Quinoxalylisoquinoline compound
JPH07304607A (en) Germicidal composition
JP4661163B2 (en) 6-Arylpyrimidinone compounds and uses thereof
JP5360244B2 (en) Plant disease control composition
JP2005089362A (en) Aryl pyrazoline compound and its application
JP3094630B2 (en) Iminium salt, method for producing the same, and agricultural / horticultural fungicide containing the same as an active ingredient
JPH0826912A (en) Fungicidal composition
JP4529535B2 (en) Bactericidal use of 4-amino [1,2,4] triazolo [4,3-a] quinoxaline compounds
JPH10168063A (en) Substituted pyrazole derivative, its production and antimicrobial agent containing the derivative as active ingredient and useful for agricultute and horticulture
JP2007297350A (en) Heterocyclic mandelic amide compound and bactericide
JP2005306805A (en) Pyrazoline compound and its application to plant disease injury control
JP2005314318A (en) APPLICATION OF 4-AMINO[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUND
WO1995011896A1 (en) Substituted pyrazole derivative and agrohorticultural fungicide
JPH07285812A (en) Germicidal composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070830

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20080128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100810

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100823

R151 Written notification of patent or utility model registration

Ref document number: 4586257

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130917

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees